Selectis Health, Inc. financial data

Symbol
GBCS on OTC
Location
8480 E. Orchard Road, Suite 4900, Greenwood Village, CO
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 19.2 % -37%
Debt-to-equity -697 % +60.7%
Return On Equity 48 %
Return On Assets -9.29 % +39.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.07M shares
Common Stock, Shares, Outstanding 3.07M shares 0%
Entity Public Float 4.75M USD -57.9%
Common Stock, Value, Issued 153K USD 0%
Weighted Average Number of Shares Outstanding, Basic 3.07M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 3.07M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 41.3M USD +10.8%
General and Administrative Expense 9.26M USD -8.97%
Operating Income (Loss) -2.14M USD +68.8%
Nonoperating Income (Expense) -1.01M USD -238%
Net Income (Loss) Attributable to Parent -3.15M USD +48.7%
Earnings Per Share, Basic -1 USD/shares +48.5%
Earnings Per Share, Diluted -1 USD/shares +48.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 560K USD -82.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.04M USD +39%
Assets, Current 4M USD -33.2%
Property, Plant and Equipment, Net 27.8M USD -3.71%
Goodwill 1.08M USD 0%
Assets 33.6M USD -8.42%
Liabilities, Current 21.2M USD +16.3%
Liabilities 40M USD +0.21%
Retained Earnings (Accumulated Deficit) -21.2M USD -17.7%
Stockholders' Equity Attributable to Parent -6.4M USD -98.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -4.01M USD -181%
Liabilities and Equity 33.6M USD -8.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.04M USD +315%
Net Cash Provided by (Used in) Financing Activities -182K USD +54.9%
Net Cash Provided by (Used in) Investing Activities -219K USD -88%
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 3.07M shares 0%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 634K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.33M USD -66.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 535K USD -22.9%
Deferred Tax Assets, Valuation Allowance 3.3M USD +17.9%
Deferred Tax Assets, Gross 4.59M USD +9.24%
Depreciation 363K USD -11.4%
Payments to Acquire Property, Plant, and Equipment 219K USD +88%
Lessee, Operating Lease, Liability, to be Paid 2.01M USD -19.2%
Property, Plant and Equipment, Gross 43.4M USD +0.91%
Lessee, Operating Lease, Liability, to be Paid, Year Two 652K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 643K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 661K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 3.01M USD +8.22%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 55.1K USD -91.7%
Additional Paid in Capital 13.9M USD 0%
Depreciation, Depletion and Amortization 439K USD -2%
Interest Expense 2.17M USD -2.58%